An experimental pill to treat Covid developed by the US company Pfizer cuts the risk of hospitalisation or death by 89% in vulnerable adults, clinical trial results suggest.
The drug – Paxlovid – is intended for use soon after symptoms develop in people at high risk of severe disease.
Pfizer says it stopped trials early as the initial results were so positive.
It comes the day after the UK medicines regulator approved a similar treatment from Merck Sharp and Dohme (MSD).
Please subscribe HERE http://bit.ly/1rbfUog
#Covid #BBCNews
Subscribe to our channel here: https://bbc.in/bbcnews For the latest news download the BBC News app or visit BBC.com/news #BBCNews
ROMA (ITALPRESS) – Si è svolta questa mattina, nella Sala Verde di Palazzo Chigi, la cerimonia di consegna del Premio…
ROMA (ITALPRESS) – “Ieri il Governo ha approvato un nuovo disegno di legge sulla sicurezza, e il messaggio che vogliamo…